Osteo Arthritis Knee: Clinical Trials

19 trials for Osteo Arthritis Knee, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 unknown, 2 not yet recruiting, 2 withdrawn. 19 Phase 2, 6 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 219Completed 10, Unknown 3, Not yet recruiting 2, Withdrawn 2, Active not recruiting 1, Recruiting 1
Phase 16Completed 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 32Completed 1, Not yet recruiting 1

Follow Osteo Arthritis Knee: new trials by email Literature Review of Osteo Arthritis Knee trials Research Report on Osteo Arthritis Knee

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of GNSC-001 Intra-articular Injection for Knee Osteoarthritis
Gene Therapy GNSC-001, Placebo - Knee Arthritis Osteoarthritis, Knee Arthritis, Osteoarthritis
Phase 2 / Phase 3Not yet recruitingGenascence Corporation2402027-07-012026-09-21
Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint
StroMel - Osteo Arthritis Knee
Phase 1 / Phase 2Not yet recruitingAkan Biosciences, LLC202025-10-012025-01-29
The Role of Vitamin K on Knee Osteoarthritis Outcomes
Vitamin K1 500 µg, K1 1000 µg, Vitamin K2 (MK-7) 300 µg - Osteo Arthritis Knee
Phase 1 / Phase 2Active not recruitingBoston University492025-06-032026-09-21
An Study to Evaluate Safety and Tolerability of OA-SYS in Subjects With Moderate to Severe Osteoarthritis of the Knee Joint
OA-SYS - Osteoarthritis, Osteo Arthritis Knee
Phase 2RecruitingAgeless Biotech, Inc.4002025-05-212025-09-18
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, 2.5% Diclofenac Patches - Osteo Arthritis Knee, Arthritis
Phase 2CompletedZetrOZ, Inc.3072024-10-012026-06-30
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte) - Osteo Arthritis Knee
Phase 1 / Phase 2CompletedCellcolabs Clinical SPV Limited122023-11-072026-04-16
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Knee Pain Related to Osteoarthritis
Sustained Acoustic Device with 2.5% Diclofenac Patch, Sustained Acoustic Device with 0% Diclofenac Patch, 2.5% Diclofenac Patches - Osteo Arthritis Knee, Arthritis
Phase 2CompletedZetrOZ, Inc.2002023-06-032025-05-15
"Ready-to-use" Intra-articular Formulation of Mesenchymal Stromal Cells
"Ready to inject" Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product, Resuspended Umbilical cord-derived Mesenchymal Stromal Cell (MSC) product - Osteo Arthritis Knee
Phase 2UnknownUniversidad de los Andes, Chile602023-04-012023-03-02
Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee
LEVI-04, Placebo - Pain, Osteo Arthritis Knee
Phase 2CompletedLevicept5182022-10-192025-11-20
Efficacy of Duloxetine Compared to NSIADs in Osteoarthritis of Knee
Duloxetine 30 MG, Nonsteroidal Antiinflammatory Drug - Osteo Arthritis Knee
Phase 2CompletedHawler Medical University2002022-08-202023-03-14
OA Optimization Program Pilot Trial
Alberta Healthy Living Program, Alberta Obesity Centre Program, Osteoarthritis advice - Osteo Arthritis Knee, Osteoarthritis, Knee
Phase 1 / Phase 2UnknownUniversity of Calgary702022-06-282024-05-22
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
LY3526318, Placebo - Osteoarthritis, Osteo Arthritis Knee
Phase 2CompletedEli Lilly and Company1602021-10-122024-07-17
pAF for the Treatment of Osteoarthritis
Amniotic Fluid Injection, Standard of Care - Osteo Arthritis Knee
Phase 1 / Phase 2CompletedUniversity of Utah602021-07-082026-03-27
The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis
Metformin, Placebo - Osteo Arthritis Knee
Phase 1 / Phase 2WithdrawnSadat City University2021-02-162025-07-14
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee
Phase 2 / Phase 3CompletedQueen Savang Vadhana Memorial Hospital, Thailand932020-08-032023-02-21
Conventional Platelet-Rich Plasma Versus Concentrated Bone Marrow Stem Cell Injections for Osteoarthritis of the Knee
Concentrated Bone Marrow Aspirate (BMAC), Platelet-Rich Plasma (PRP) - Osteo Arthritis Knee
Phase 2WithdrawnMayo Clinic2019-09-012019-12-24
Knee Arthritis Treatment With Autologous Fragmented Adipose Tissue and PRP - Comparison of Two Treatment Methods
autologous adipose tissue transfer, PRP injections - Osteo Arthritis Knee, Knee Osteoarthritis
Phase 2UnknownRehasport Clinic602018-07-302020-03-25
Intra-articular Injection of Allogenic Lyophilized Growth Factors in Primary Knee Osteoarthritis
allogenic lyophilized growth factors - Osteo Arthritis Knee
Phase 2CompletedRasmia Elgohary312017-05-012021-01-28
A Study to Evaluate the Analgesic Efficacy and Safety of V120083 in Subjects With Osteoarthritis (OA) of the Knee
V120083, Naproxen, Placebo - Osteo Arthritis Knee
Phase 2CompletedPurdue Pharma LP2912017-03-142019-02-12

Narrower conditions

Osteoarthritis (9)  ·  Osteoarthritis, Knee (5)  ·  Arthritis (4)  ·  Joint Diseases (3)  ·  Pain (3)  ·  Insomnia, Fatal Familial (1)  ·  Musculoskeletal Diseases (1)  ·  Osteoarthritis, Hip (1)  ·  Rheumatic Diseases (1)

Broader conditions

Musculoskeletal Diseases (12)  ·  Joint Diseases (10)  ·  Rheumatic Diseases (10)  ·  Arthritis (9)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Osteoarthritis (2)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Infections (1)  ·  Connective Tissue Diseases (1)  ·  Dyssomnias (1)  ·  Infections (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)

Interventions

Adrenal Cortex Hormones (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Duloxetine Hydrochloride (1)  ·  Educational Status (1)  ·  Exercise (1)  ·  MICU1 protein, human (1)  ·  Metformin (1)  ·  Naproxen (1)  ·  Pharmaceutical Preparations (1)  ·  Physical Therapy Modalities (1)  ·  Platelet Activating Factor (1)  ·  Standard of Care (1)  ·  Sugars (1)  ·  Vitamin K 1 (1)  ·  Vitamin K 2 (1)

Sponsors

ZetrOZ, Inc. (2)  ·  Ageless Biotech, Inc. (1)  ·  Akan Biosciences, LLC (1)  ·  Boston University (1)  ·  Cellcolabs Clinical SPV Limited (1)  ·  Eli Lilly and Company (1)  ·  Genascence Corporation (1)  ·  Hawler Medical University (1)  ·  Levicept (1)  ·  Mayo Clinic (1)  ·  Purdue Pharma LP (1)  ·  Queen Savang Vadhana Memorial Hospital, Thailand (1)  ·  Rasmia Elgohary (1)  ·  Rehasport Clinic (1)  ·  Sadat City University (1)

Countries

United States (9)  ·  Egypt (2)  ·  Poland (2)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Iraq (1)  ·  Moldova (1)  ·  Puerto Rico (1)  ·  Thailand (1)  ·  United Arab Emirates (1)

Top investigators

George K Lewis, Ph.D. (2)  ·  David Petron, MD (1)  ·  Fahti Yousef, PhD (1)  ·  Fernando E Figueroa, M.D. (1)  ·  Jean Liew, MD MS (1)  ·  Kamel Gado, MD (1)  ·  Niaz Albarzinji, MBCHB,DRMR (1)  ·  Pawel Bakowski, MD PhD (1)  ·  Shane A Shapiro (1)  ·  Simon Westbrook (1)  ·  Surapol Athiprayul, MD (1)  ·  Tomasz Piontek, MD PhD (1)

Results publications

PMID 12081113, PMID 1991946, PMID 25035839, PMID 25161985, PMID 25925602, PMID 26432430, PMID 28012636, PMID 28386761, PMID 30623236, PMID 30632533, PMID 32434498, PMID 33754800, PMID 34826301, PMID 35103547, PMID 41905364

NIH funding

K23AR082938 (1)